Rebound effect after stopping beta-blockers.

Beta-Blockers and Depression After Myocardial Infarction

OBJECTIVES The purpose of this research was to explore the prospective relationship between the use of beta-blockers and depression in myocardial infarction (MI) patients. BACKGROUND Beta-blocker use has been reported to be associated with the development of depression, but the methodological quality of studies in this field is weak. METHODS In a multicenter study, MI patients (n 127 non–beta-b...

Hemangiomas and β-Blockers: On the Rebound.

Infantile hemangioma (IH) is the most common tumor of childhood, and although most lesions eventually involute, the proliferative phase may be associated with complications, such as ulceration, bleeding, functional compromise, and anatomic disfigurement. Rarely, IH can have major or life-threatening consequences, such as airway obstruction, high-output congestive heart failure, and consumptive ...

A "Rebound Effect" After Stereotype Threat?

Two studies investigated a potential cognitive mediator for stereotype threat, a phenomenon whereby the mere threat of confirming a negative stereotype results in a performance deficit. It was hypothesized that people attempt to suppress stereotypes in memory during threatening situations, consuming cognitive resources, but that the suppression is released after the threatening situation has en...

Beta-blockers.

Dynamics of viral load rebound and immunological changes after stopping effective antiretroviral therapy.

BACKGROUND This study addresses the dynamic of viral load rebound and immune system changes in a cohort of eight consecutive HIV-1-infected patients in very early stages [all the patients were taking highly active antiretroviral therapy (HAART} and were recruited in the coordinating center from a larger study] who decided to discontinue HAART after 1 year of treatment and effective virologic re...